Work

First experience of the application of beremagene geperpavec genetically engineered drug for treatment of congenital dystrophic epidermolysis bullosa in the Russian Federation

Year: 2025

Type: article

Study design: Case Report

Source: Russian Journal of Clinical Dermatology and Venereology

DOI: 10.17116/klinderma202524061822

Authors: N.N. Potekaev, O.V. Porshina, O.V. Zhukova

Institutions: Pirogov Russian National Research Medical University, Peoples' Friendship University of Russia

Language: English

Topic: Skin and Cellular Biology Research

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7117373937

FWCI:

Cites: 10

Cited by:

Related to: